// App-Quantinova.ai

: Quality of Life in Patients with Clinically Severe Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe Von Willebrand Disease (VWD)

Researchers

Presenter

  • Angela C. Weyand

Principal Investigators

  • Martin Chandler

  • Carol Fedor

  • Michael Recht

  • Robert F. Sidonio

Medical Centers

  • Aflac Cancer and Blood Disorders Center, Emory University, Decatur, GA

  • University of Michigan, Ann Arbor, MI

  • American Thrombosis and Hemostasis Network, Rochester, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

  • Blood/haematological Diseases

Disease

  • Depression

  • Venous thrombosis

  • Anxiety

Biomarkers

  • von Willebrand factor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved